M&T Bank Corp Has $681,000 Stock Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

M&T Bank Corp increased its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 53.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,228 shares of the company’s stock after purchasing an additional 1,120 shares during the quarter. M&T Bank Corp’s holdings in Inspire Medical Systems were worth $681,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp lifted its stake in shares of Inspire Medical Systems by 78.0% in the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock valued at $221,557,000 after purchasing an additional 459,990 shares during the period. Point72 Asset Management L.P. increased its holdings in Inspire Medical Systems by 954.4% in the third quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock valued at $67,402,000 after purchasing an additional 289,075 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Inspire Medical Systems by 798.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock valued at $56,530,000 after buying an additional 238,034 shares during the period. Bank of New York Mellon Corp boosted its holdings in Inspire Medical Systems by 32.3% during the second quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock worth $105,433,000 after buying an additional 192,238 shares during the last quarter. Finally, AQR Capital Management LLC grew its position in shares of Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after buying an additional 140,090 shares during the period. 94.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Robert W. Baird increased their target price on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a report on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price target for the company from $220.00 to $255.00 in a report on Wednesday, November 20th. Wells Fargo & Company lifted their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. Finally, Leerink Partners increased their price target on Inspire Medical Systems from $167.00 to $197.00 and gave the stock a “market perform” rating in a report on Tuesday, September 10th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $233.58.

Inspire Medical Systems Stock Up 0.5 %

Shares of INSP stock opened at $188.73 on Tuesday. The firm has a market cap of $5.66 billion, a PE ratio of 176.38 and a beta of 1.31. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The company’s fifty day simple moving average is $193.93 and its 200-day simple moving average is $179.07.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.29) EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 1.33 earnings per share for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.